Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction
Sponsor: Asfendiyarov Kazakh National Medical University
Listed as NCT06953180, this observational or N/A phase trial focuses on Cardiovascular Diseases (CVD) and Chronic Kidney Diseases and remains actively recruiting participants. Sponsored by Asfendiyarov Kazakh National Medical University, it has been updated 3 times since 2025, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
3 versions recorded-
Aug 2025 — Present [monthly]
Recruiting
-
Jul 2025 — Aug 2025 [monthly]
Recruiting
-
Jun 2025 — Jul 2025 [monthly]
Recruiting
First recorded
Mar 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asfendiyarov Kazakh National Medical University
For direct contact, visit the study record on ClinicalTrials.gov .